CAS: 926037-48-1 - 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide
Fórmula:C27H21F3N8O
InChI:InChI=1S/C27H21F3N8O/c1-16-3-4-18(9-23(16)37-26-33-6-5-22(36-26)24-13-31-7-8-32-24)25(39)35-20-10-19(27(28,29)30)11-21(12-20)38-14-17(2)34-15-38/h3-15H,1-2H3,(H,35,39)(H,33,36,37)
Chave InChI:InChIKey=DUPWHXBITIZIKZ-UHFFFAOYSA-N
SMILES:O=C(NC=1C=C(C=C(C1)C(F)(F)F)N2C=NC(=C2)C)C3=CC=C(C(=C3)NC=4N=CC=C(N4)C5=NC=CN=C5)C
- Sinónimos:
- 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(2-pyrazinyl)-2-pyrimidinyl]amino]benzamide
- 4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide
- Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(2-pyrazinyl)-2-pyrimidinyl]amino]-
- Radotinib
- Unii-I284Ljy110
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Supect REF: IN-DA00H1JDCAS: 926037-48-1 | % | 48,00 €~501,00 € | Ter 07 Jan 25 | |
Radotinib REF: 4Z-R-114001CAS: 926037-48-1 | - - - | A consultar | Ter 07 Jan 25 | |
Radotinib-d6 REF: 4Z-R-114002CAS: 926037-48-1 | - - - | A consultar | Ter 07 Jan 25 | |
Radotinib REF: TM-T2328CAS: 926037-48-1 | 99.39% - 99.97% | 46,00 €~807,00 € | Seg 13 Jan 25 | |
Radotinib REF: 3D-FR103403CAS: 926037-48-1 | Min. 95% | 260,00 €~1.135,00 € | Qua 15 Jan 25 |
Ref: IN-DA00H1JD
10mg | 48,00 € | ||
25mg | 73,00 € | ||
50mg | 120,00 € | ||
100mg | 166,00 € |
Ref: 4Z-R-114001
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Ref: 4Z-R-114002
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Radotinib
Ref: TM-T2328
5mg | 46,00 € | ||
10mg | 64,00 € | ||
25mg | 118,00 € | ||
50mg | 185,00 € | ||
100mg | 346,00 € | ||
500mg | 807,00 € |
Radotinib
Ref: 3D-FR103403
5mg | 260,00 € | ||
10mg | 386,00 € | ||
25mg | 542,00 € | ||
50mg | 775,00 € | ||
100mg | 1.135,00 € |